2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Behcet Syndrome: new trials by email Literature Review of Behcet Syndrome trials Research Report on Behcet Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivarmacitinib for Refractory Behcet's Syndrome Ivarmacitinib - Behcet's Syndrome | Phase 2 | Withdrawn | Liu Tian | 2026-06-01 | 2026-07-10 | |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease XOMA 052 - Muckle Wells Syndrome, Autoinflammatory | Phase 1 / Phase 2 | Withdrawn | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 | 2017-07-02 |
Cryopyrin-Associated Periodic Syndromes (1)
Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Genetic Diseases, Inborn (2) · Hereditary Autoinflammatory Diseases (2) · Mouth Diseases (2) · Panuveitis (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Stomatognathic Diseases (2) · Uveal Diseases (2) · Uveitis (2) · Uveitis, Anterior (2)
gevokizumab (1) · ivarmacitinib (1)
Liu Tian (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
China (1) · United States (1)